Deepak Khanna

UK drug pricing: ABPI wants evolution, not revolution

June 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing

 As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

screen_shot_2012-06-14_at_14

Conor Griffin joins Tudor Reilly’s senior team

June 14, 2012
Business Services, Medical Communications, Sales and Marketing Conor Griffin, Tudor Reilly, healthcare comms

Healthcare specialist Tudor Reilly has strengthened its senior management with the appointment of Conor Griffin as director.  He joins the …

New chair of Health Research Authority confirmed by DH

June 14, 2012
Medical Communications, Research and Development, Sales and Marketing

Professor Jonathan Montgomery will head up the Health Research Authority, the new organisation that will protect and promote the interests …

Social media

ABPI: we don’t have the answers for digital yet

June 14, 2012
Medical Communications, Sales and Marketing ABPI, Bayer, Deepak Khanna, Shire, digital, online

Pharma’s use of digital media is posing questions that can’t yet be answered, says the new ABPI president Deepak Khanna. …

AstraZeneca swings axe at Swedish plant

June 14, 2012
Sales and Marketing AstraZeneca, Brennan, Sweden, Södertälje, cuts

AstraZeneca will be cutting 400 jobs from its facility in Sweden, the company has confirmed.  Speaking to the TT news …

sanofi website

Positive data for Sanofi’s diabetes drug

June 13, 2012
Research and Development, Sales and Marketing Lyxumia, Novo Nordisk, Sanofi, Victoza, diabetes

Sanofi’s new diabetes treatment Lyxumia has significantly reduced glycated hemoglobin (HbA1c) in two late-stage trials, the manufacturer says. Paris-based Sanofi …

GSK pays £146 million for eczema drug

June 13, 2012
Sales and Marketing Basilea, GSK, Stiefel, Toctino

GlaxoSmithKline has paid £146 million for Basilea Pharmaceutica’s dermatology drug Toctino. Toctino (alitretinoin) is approved for the treatment of adults …

New appointments at Events 4 Healthcare

June 13, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing Events 4 Healthcare, NHS

Events 4 Healthcare has announced two new appointments to enhance the team on the back of a number of new …

AmerisourceBergen merges pharma packing units

June 12, 2012
Manufacturing and Production AmericsourceBergen, Anderson Packaging, Taylor

Brecon Pharmaceuticals of the UK has officially joined forces with US firm Anderson Packaging to form a new pharma-focused packaging …

screen_shot_2012-06-12_at_15

Ark Therapeutics appoints new head of business development

June 12, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ark Therapeutics, Bachem, Eden Biodesign, Watson

Ark Therapeutics has announced that Kassim Kolia has been appointed as head of business development.  In this role, Kolia will …

bob_harrell

Appature appoints new vice president Bob Harrell

June 12, 2012
Business Services, Medical Communications, Sales and Marketing Appature, Harrell, Med Comms, cloud-based, saas

Cloud-based software company Appature has appointed Bob Harrell as the company’s new vice president of marketing, healthcare. Appature, a software-as-a-service …

NHS confidence in ‘freefall’

June 12, 2012
Sales and Marketing NHS, freefall, government, king's fund, reforms

The Department of Health has disputed a report which says that people’s confidence in the NHS is in freefall. British …

It's in your hands website image

Pfizer launches new website for Dupuytren’s disease

June 12, 2012
Medical Communications, Sales and Marketing Dupuytren's disease, Pfizer, Xiapex, it is in your hands

Pfizer has released a new interactive video and website aimed at helping people with Dupuytren’s disease, a debilitating hand condition. …

Sanofi submits key MS pill for approval

June 12, 2012
Research and Development, Sales and Marketing Bayer, EMA, FDA, Genzyme, Lemtrada, MS, Sanofi

Sanofi has submitted its multiple sclerosis pill Lemtrada for regulatory reviews in the US and Europe. Lemtrada (alemtuzumab), originally developed …

Packaging errors spark fourth oral contraceptive recall

June 12, 2012
Manufacturing and Production Introvale, Novartis, Sandoz, manufacturing, recall

There has been yet another case of an oral contraceptive being recalled because packaging errors could lead to unwanted pregnancy, …

Siegfried buys AMP to enter sterile filling sector

June 12, 2012
Manufacturing and Production AMP, Alliance Medical Products, Siegfried

Switzerland-based Siegfried Holding has entered the market for sterile filling services with the acquisition of US contract manufacturing organisation (CMO) …

Abbott sets out AbbVie stall for shareholders

June 12, 2012
Manufacturing and Production AbbVie, Abbott, CRO, Taylor, manufacturing

Abbott Laboratories has issued the prospectus for its planned separation of its pharmaceutical operations into a standalone company called AbbVie …

Jane Griffiths

Working Life: Jane Griffiths

June 11, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Working Life, brett wells, jane griffiths

After completing her PhD in Biochemistry at the University of Aberystwyth in 1982, Jane worked her way up the Johnson …

FDA approves Roche’s breast cancer drug

June 11, 2012
Sales and Marketing EMA, FDA, Perjeta, Roche, breast cancer

US regulators have approved Roche’s new breast cancer drug after granting it a priority review to speed up the process. …

BMS invests $15 million in Asian diabetes programme

June 11, 2012
Sales and Marketing Asia, BMS, China, India, Onglyza, diabetes

Bristol-Myers Squibb has invested $15 million into its ‘Together on Diabetes’ campaign in India and China. Together on Diabetes is …

The Gateway to Local Adoption Series

Latest content